Las Vegas, NV -- (SBWIRE) -- 12/09/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), CombiMatrix Corporation (NASDAQ:CBMX), EnteroMedics Inc (NASDAQ:ETRM), Frontline Ltd. (NYSE:FRO)
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) managed to keep its fall at -3.58% on above-normal volume of 2.75M shares. The stock settled at $8.90 after floating in a range of $8.68 to $9.34. Its latest price has reached market capitalization of $72 million. Its 52-week range has been $3.21 to $12.80. JA Solar Holdings Co., Ltd. (JA Solar) is engaged in the business of designing, developing, manufacturing and selling solar cell and solar module products. The Company is also engaged in the manufacturing and sales of solar cells. Its principal products are monocrystalline and multicrystalline solar cells and it also manufacture a variety of standard and specialty solar modules. JA Solar sells its products under the JA Solar brand name and also produces original equipment for manufacturer (OEM), customers under their brand names.
Has JASO Found The Bottom and Ready To Move Up? Find Out Here
CombiMatrix Corporation (NASDAQ:CBMX) traded up on a volume of 2.54 million, higher than its standard daily volume. Shares have gained 1.69% to $3. Over the last twelve months, the stock has lost-65.12% and faced a worst price of $1.97. CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc. located in Irvine, California. The Company operates as a diagnostics reference laboratory, providing DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics. The Company's BAC arrays enable the Company to perform aCGH studies to evaluate genomic alterations.
For How Long CBMX’s Gloss will Attract Investors? Find out via this report
EnteroMedics Inc (NASDAQ:ETRM) settled -6.70% lower at $1.95 on above-normal volume of 2.52M shares during the last trading day. The stock has its 12-month high at $3.23 and 52-week low price was $0.81. It traded in a range of $1.87 to $2.07 during the last trading day. EnteroMedics Inc. (EnteroMedics) is a development- stage medical device company. The Company focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.
Will ETRM Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Frontline Ltd. (NYSE:FRO) was down on high volume, trading at a volume of 2.28M versus its average daily volume of 1.57 million shares. At $3.31, the stock has attained market capitalization of 260.97 million. Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker. The Company operates oil tankers of two sizes: Very Large Crude Carriers (VLCCs), which are between 200,000 and 320,000 deadweight tonnages (dwt), and Suezmax tankers, which are vessels between 120,000 and 170,000 dwt. The Company operates through subsidiaries and partnerships located in the Bahamas, Bermuda, the Cayman Islands, India, the Isle of Man, Liberia, Norway, the United Kingdom and Singapore.
Why Should Investors Buy FRO After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)